» Articles » PMID: 31373305

Structure-Based Virtual Screening Allows the Identification of Efficient Modulators of E-Cadherin-Mediated Cell-Cell Adhesion

Abstract

Cadherins are a large family of transmembrane calcium-dependent cell adhesion proteins that orchestrate adherens junction formation and are crucially involved in tissue morphogenesis. Due to their important role in cancer development and metastasis, cadherins can be considered attractive targets for drug discovery. A recent crystal structure of the complex of a cadherin extracellular portion and a small molecule inhibitor allowed the identification of a druggable interface, thus providing a viable strategy for the design of cadherin dimerization modulators. Here, we report on a structure-based virtual screening approach that led to the identification of efficient and selective modulators of E-cadherin-mediated cell-cell adhesion. Of all the putative inhibitors that were identified and experimentally tested by cell adhesion assays using human pancreatic tumor BxPC-3 cells expressing both E-cadherin and P-cadherin, two compounds turned out to be effective in inhibiting stable cell-cell adhesion at micromolar concentrations. Moreover, at the same concentrations, one of them also showed anti-invasive properties in cell invasion assays. These results will allow further development of novel and selective cadherin-mediated cell-cell adhesion modulators for the treatment of a variety of cadherin-expressing solid tumors and for improving the efficiency of drug delivery across biological barriers.

Citing Articles

Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker.

Dai Z, Peng X, Cui X, Guo Y, Zhang J, Shen X J Cancer Res Clin Oncol. 2023; 149(14):13087-13106.

PMID: 37474678 DOI: 10.1007/s00432-023-05163-6.


Artificial Intelligence-Based Computational Screening and Functional Assays Identify Candidate Small Molecule Antagonists of PTPmu-Dependent Adhesion.

Molyneaux K, Laggner C, Brady-Kalnay S Int J Mol Sci. 2023; 24(5).

PMID: 36901713 PMC: 10001486. DOI: 10.3390/ijms24054274.


A combined fragment-based virtual screening and STD-NMR approach for the identification of E-cadherin ligands.

Vasile F, Lavore F, Gazzola S, Vettraino C, Parisini E, Piarulli U Front Chem. 2022; 10:946087.

PMID: 36059878 PMC: 9437437. DOI: 10.3389/fchem.2022.946087.


Editorial to the Special Issue "Activations of Cadherin Signaling in Cancer".

Tomassetti A Int J Mol Sci. 2022; 23(13).

PMID: 35806026 PMC: 9266632. DOI: 10.3390/ijms23137022.


Effect of MiR-375 Regulates YAP1 on the Invasion, Apoptosis, and Epithelial-Mesenchymal Transition of Cervical Cancer HeLa Cells.

Hu Y, Ma Y, Luo G, Liao W, Zhang S, Li G Evid Based Complement Alternat Med. 2021; 2021:3088723.

PMID: 34512774 PMC: 8429006. DOI: 10.1155/2021/3088723.


References
1.
Pertz O, Bozic D, Koch A, Fauser C, Brancaccio A, Engel J . A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J. 1999; 18(7):1738-47. PMC: 1171260. DOI: 10.1093/emboj/18.7.1738. View

2.
Gerhardt H, Wolburg H, Redies C . N-cadherin mediates pericytic-endothelial interaction during brain angiogenesis in the chicken. Dev Dyn. 2000; 218(3):472-9. DOI: 10.1002/1097-0177(200007)218:3<472::AID-DVDY1008>3.0.CO;2-#. View

3.
Blaschuk O, Rowlands T . Cadherins as modulators of angiogenesis and the structural integrity of blood vessels. Cancer Metastasis Rev. 2001; 19(1-2):1-5. DOI: 10.1023/a:1026522216059. View

4.
Liao F, Doody J, Overholser J, Finnerty B, Bassi R, Wu Y . Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res. 2002; 62(9):2567-75. View

5.
Corada M, Zanetta L, Orsenigo F, Breviario F, Lampugnani M, Bernasconi S . A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood. 2002; 100(3):905-11. DOI: 10.1182/blood.v100.3.905. View